Loading clinical trials...
Loading clinical trials...
A Multicenter, Single-arm, Prospective Study to Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
Conditions
Interventions
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
Locations
1
China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Start Date
May 28, 2024
Primary Completion Date
July 1, 2027
Completion Date
July 1, 2027
Last Updated
July 18, 2024
NCT06326346
NCT05493215
NCT05385549
NCT06431451
NCT05440357
NCT06523582
Lead Sponsor
First Affiliated Hospital of Chongqing Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions